Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung CancerRosalyn A. Juergens, Charles M. Rudin, Igor Espinoza Delgado et al.|Cancer Discovery|2011Cited by 681
Abstract ED03-04: Using epigenetic biomarkers as prognostic and predictive markers in non-small cell lung cancer (NSCLC) and the promise of epigenetic therapyMalcolm V. Brock, Charles M. Rudin, Rosalyn A. Juergens et al.|Cancer Epidemiology Biomarkers & Prevention|2011Cited by 0
Press Conference from Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung CancerRosalyn A. Juergens, Charles M. Rudin, John Wrangle et al.|Unknown|2023Cited by 0
Press Conference from Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung CancerRosalyn A. Juergens, Charles M. Rudin, John Wrangle et al.|Unknown|2023Cited by 0
Data from Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung CancerRosalyn A. Juergens, Charles M. Rudin, John Wrangle et al.|Unknown|2023Cited by 0